Keywords
How to Cite
Abstract
This thesis examines the effectiveness of using molecular hydrogen as part of comprehensive therapy for headache in patients with arterial hypertension and chronic cerebral ischemia. The relevance of the study is обусловлена by the high prevalence of cephalgic syndrome in this category of patients and the need to explore additional therapeutic approaches aimed not only at reducing the severity of headache but also at correcting the pathogenetic mechanisms of cerebrovascular disorders. Particular attention is paid to the potential antioxidant, anti-inflammatory, and cytoprotective effects of molecular hydrogen. The study proposes to assess changes in the intensity and frequency of headaches, their impact on patients’ daily activities, as well as changes in clinical and functional indicators during comprehensive treatment. The possibility of using molecular hydrogen as an additional component of standard therapy in patients with concomitant arterial hypertension and chronic cerebral ischemia is considered. The results may contribute to clarifying the therapeutic role of molecular hydrogen and determining the prospects for its further use in the comprehensive treatment of cerebrovascular pathology.
References
1. Ohsawa I., Ishikawa M., Takahashi K. et al. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals // Nature Medicine. — 2007. — Vol. 13. — P. 688–694. — DOI: 10.1038/nm1577.
2. Iketani M., Ohsawa I. Molecular Hydrogen as a Neuroprotective Agent // Current Neuropharmacology. — 2017. — Vol. 15, No. 2. — P. 324–331. — DOI: 10.2174/1570159X14666160607205417. (PubMed)
3. Ichihara M., Sobue S., Ito M., Ito M., Hirayama M., Ohno K. Beneficial biological effects and the underlying mechanisms of molecular hydrogen — comprehensive review of 321 original articles // Medical Gas Research. — 2015. — Vol. 5. — Article 12. — DOI: 10.1186/s13618-015-0035-1.
4. Huang L. Molecular hydrogen: a therapeutic antioxidant and beyond // Medical Gas Research. — 2016. — Vol. 6, No. 4. — P. 219–222. — DOI: 10.4103/2045-9912.196904.
5. Ono H., Nishijima Y., Adachi N. et al. A basic study on molecular hydrogen (H₂) inhalation in acute cerebral ischemia patients for safety check with physiological parameters and measurement of blood H₂ level // Medical Gas Research. — 2012. — Vol. 2. — Article 21. — DOI: 10.1186/2045-9912-2-21.
6. Nagatani K., Nawashiro H., Takeuchi S. et al. Safety of intravenous administration of hydrogen-enriched fluid in patients with acute cerebral ischemia: initial clinical studies // Medical Gas Research. — 2013. — Vol. 3. — Article 13. — DOI: 10.1186/2045-9912-3-13. (PubMed)
7. Oshita M., Hayashi Y., Sato T. et al. Molecular hydrogen in the treatment of acute and chronic neurological conditions: mechanisms of protection and routes of administration // Journal of Clinical Biochemistry and Nutrition. — 2017. — Vol. 61, No. 1. — P. 1–5. — DOI: 10.3164/jcbn.16-87. (PubMed)
8. Iketani M., Sekimoto K., Igarashi T., Takahashi M., Komatsu M., Sakane I., Takahashi H., Kawaguchi H., Ohsawa I. Administration of hydrogen-rich water prevents vascular aging of the aorta in LDL receptor-deficient mice // Scientific Reports. — 2018. — Vol. 8. — Article 16822. — DOI: 10.1038/s41598-018-35239-0.
9. Ramanathan D., Huang L., Wilson T., Boling W. Molecular hydrogen therapy for neurological diseases: a review of current evidence // Medical Gas Research. — 2023. — Vol. 13, No. 3. — P. 94–98. — DOI: 10.4103/2045-9912.359677. (PubMed Central (PMC))
10. Wu C. et al. Molecular Hydrogen: an Emerging Therapeutic Medical Gas for Brain Disorders // Molecular Neurobiology. — 2023. — Vol. 60, No. 4. — P. 1749–1765. — DOI: 10.1007/s12035-022-03175-w. (PubMed)
11. Li H., Luo Y., Yang P., Liu J. Hydrogen as a complementary therapy against ischemic stroke: A review of the evidence // Journal of the Neurological Sciences. — 2019. — Vol. 396. — P. 240–246. (PubMed)
12. Liu B., Xue J., Zhang M. et al. Neuroprotective Effects of Molecular Hydrogen: A Critical Review // Neuroscience Bulletin. — 2021. — Vol. 37. — P. 389–404. (PubMed Central (PMC))